Study suggests obese patients have more advanced, aggressive papillary thyroid cancer

May 21, 2012

A review of medical records of patients treated at an academic tertiary care center suggests that obese patients present to their physicians with more advanced stage and more aggressive forms of papillary thyroid cancer (PTC), according to a report published Online First by Archives of Surgery.

Thyroid cancer is on the rise on the United States and most of the increase is due to PTC, although the authors write that it is debatable whether the increase is caused by an enhanced risk of cancer or an increase in detection. Obesity is recognized as a risk factor for a variety of cancers, the authors provide as study background.

"Our study shows that those patients with increasing BMI have a progressively increasing risk in presenting with late-stage PTC. This finding is especially seen in the obese and morbidly obese populations," the researchers comment.

Avital Harari, M.D., and colleagues at the UCLA David Geffen School of Medicine, Los Angeles, reviewed the of all patients older than 18 who underwent total thyroidectomy (removal of most or all of the ) as an initial procedure for PTC or its variants from January 2004 through March 2011.

The final analysis included 443 patients with an average age of 48.2 years. Patients were divided into four BMI (body mass index) groups: normal (18.5-24.9), overweight (25-29.9), obese (30-39.9) and morbidly obese (≥40).

"Greater BMI was associated with more advanced disease stage at presentation. Specifically, the obese and morbidly obese categories presented more as stage III or IV disease," according to the study results.

Researchers also note the obese and morbidly obese groups also presented with a higher prevalence of PTC tall cell variant, "suggesting that these groups have a higher risk of more aggressive tumor types."

"Given our findings, we believe that obese patients are at a higher risk of developing aggressive thyroid cancers and thus should be screened for thyroid cancer by sonography, which has been shown to be more sensitive in detecting thyroid cancer than physical examination alone," the authors conclude.

In an invited critique, Quan-Yang Duh, M.D., of the University of California, San Francisco, writes: "Harari and colleagues from UCLA (University of California, Los Angeles) showed us one more reason to be concerned about the current obesity epidemic – obese patients have more advanced thyroid cancer."

Duh continues: "This parallel increase in the rates of obesity and thyroid cancer is intriguing, but without a much larger population study, we cannot determine whether obesity causes thyroid cancer. However, the authors found that higher is associated with a later stage of thyroid cancer."

"For obese patients with , the bad news is that the cancer is likely to be more advanced. The good news is that operation remains safe even in with advanced disease," Duh concludes.

More information: Arch Surg. Published Online May 21, 2012. doi:10.1001/archsurg.2012.713
Arch Surg. Published online May 21, 2012. doi:10.1001/archsurg.2012.911

Related Stories

Recommended for you

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.